Cost-effectiveness of herpes zoster vaccine: flawed assumptions regarding efficacy against postherpetic neuralgia
- PMID: 17990240
- DOI: 10.1086/523011
Cost-effectiveness of herpes zoster vaccine: flawed assumptions regarding efficacy against postherpetic neuralgia
Comment on
-
Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.Clin Infect Dis. 2007 May 15;44(10):1280-8. doi: 10.1086/514342. Epub 2007 Apr 3. Clin Infect Dis. 2007. PMID: 17443464
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
